Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion type Assertion NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_head.
- NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion description "[In contrast, SOCE agonists should attenuate mTOR inhibitors-mediated AKT reactivation and consequently potentiate their efficacy in the treatment of the patients with TSC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_provenance.
- NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion evidence source_evidence_literature NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_provenance.
- NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion SIO_000772 23108404 NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_provenance.
- NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion wasDerivedFrom befree-20140225 NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_provenance.
- NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_assertion wasGeneratedBy ECO_0000203 NP299092.RAlKCqfXFoTW9Kb1_gJIH8Qw7H2cdDA03Xi_x-d6iflko130_provenance.